Sana Biotechnology, Inc. (SANA) Financial Statements
Free cash flow over the same period: -$135.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SANASana Biotechnology, Inc.Follow SANA — free
—
Price chart with a free account
- Market cap
- 697.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Research & development | 0.25 | 0.29 | 0.26 | 0.22 | 0.13 | 0.12 | |
| Operating income | -0.36 | -0.27 | -0.29 | -0.27 | -0.25 | -0.22 | |
| Pre-tax income | -0.36 | -0.27 | -0.28 | -0.27 | -0.24 | -0.21 | |
| Income tax | — | — | — | — | 0.00 | — | |
| Net income | -0.36 | -0.27 | -0.28 | -0.27 | -0.24 | -0.21 | |
| Diluted EPS ($) | -2.14 | -1.43 | -1.46 | -1.16 | -0.96 | -0.72 | |
| Diluted shares (bn) | — | 0.188 | 0.195 | 0.231 | 0.253 | — |
USD billions · SEC XBRL
Sana Biotechnology, Inc. — questions
- What is Sana Biotechnology, Inc.'s net income?
- -$211.8M over the twelve months to 2026-06-30.
- What is Sana Biotechnology, Inc.'s free cash flow?
- -$135.1M over the twelve months to 2026-06-30.
- What are Sana Biotechnology, Inc.'s diluted earnings per share?
- $-0.72 over the twelve months to 2026-06-30.
Every figure on this page comes from Sana Biotechnology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.